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Abstract With intensiﬁed treatment leading to longer
survival, complications of therapy for brain tumours are
more frequently observed. Regarding radiation therapy,
progressive and irreversible white matter disease with
cognitive decline is most feared. We report on four patients
with reversible clinical and radiological features occurring
years after radiation for brain tumours, suggestive for the
so called SMART syndrome (stroke-like migraine attacks
after radiation therapy). All four patients (males, age 36–60
years) had been treated with focal brain radiation for a
primary brain tumour or with whole-brain radiation therapy
for brain metastases. Ranging from 2 to 10 years following
radiation therapy patients presented with headache and
focal neurological deﬁcits, suggestive for tumour recur-
rence. Two patients also presented with focal seizures.
MRI demonstrated typical cortical swelling and contrast
enhancement, primarily in the parieto-occipital region. On
follow-up both clinical and MRI features improved spon-
taneously. Three patients eventually proved to have tumour
recurrence. The clinical and radiological picture of these
patients is compatible with the SMART syndrome, a rare
complication of radiation therapy which is probably under
recognized in brain tumour patients. The pathophysiology
of the SMART syndrome is poorly understood but bears
similarities with the posterior reversible encephalopathy
syndrome (PRES). These four cases underline that the
SMART syndrome should be considered in patients for-
merly treated with radiation therapy for brain tumours, who
present with new neurologic deﬁcits. Before the diagnosis
of SMART syndrome can be established other causes, such
as local tumour recurrence, leptomeningeal disease or
ischemic disease should be ruled out.
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Introduction
With improved treatments for brain tumours leading to
longer survival, late complications of therapy are more
frequently observed. The development of new neurological
symptoms following brain tumour treatment is primarily
suggestive for tumour recurrence, but when this has been
ruled out, adverse treatment effects as a cause of the
symptoms should be considered. Amongst late complica-
tions of radiation therapy, progressive leukoencephalopa-
thy with cognitive decline and focal radiation necrosis
mimicking recurrent tumour growth are the most worri-
some [1].
We report on four patients with reversible clinical and
radiological features occurring years after radiation for
brain tumours, suggestive for the so-called SMART
syndrome: stroke-like migraine attacks after radiation
therapy [2–4].
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Patient 1
In 1999 at age 32 years, this man had progressive headache
and diplopiadue toanobstructive hydrocephalus causedbya
pineal tumour. Following resection a pineoloma with
malignant histological features was diagnosed. MRI of the
craniospinal axis and CSF examination demonstrated no
other tumour localizations. He was subsequently treated with
craniospinalirradiation(36 Gyin20fractionswithaboostof
18 Gy to the original tumour site). Following a minor head
trauma 4 years after RT he developed increasing headache
over the following days and a left hemianopia. No tumour
recurrence was observed on MRI, nor in the cerebrospinal
ﬂuid(CSF) (Table 1).Additionalimaging ruled out ischemic
stroke, vertebral artery dissection and venous sinus throm-
bosis.However,onMRI,gyralthickeningoftherightparieto-
occipitalcortexwithcontrastenhancementwasseen(Fig. 1a,
b). During hospitalisation he developed several generalized
seizures with persistent post-ictal weakness of the left arm
and confusion, lasting for several weeks. He was treated with
valproate and levetiracetam. EEG showed slowing over the
right hemispherebut no epileptic activity. The observedMRI
abnormalities recovered over the weeks thereafter, with
concomitant clinical improvement (Fig. 1c, d).
Twoyearslaterhedevelopedasimilarclinicalepisodefor
whichhewasadmittedoncemore,thistimewithoutseizures.
The same imaging abnormalities were observed which
resolved once again over the following months without any
treatment. Again, no tumour recurrence could be
demonstrated.
However, in 2008, 8 years after the initial presentation
he did develop spinal leptomeningeal metastases, for which
he was treated with focal RT and systemic chemotherapy.
Patient 2
In 1997 at age 50 years, this man was treated for small cell
lung cancer and two brain metastases with systemic che-
motherapyandwhole-brainradiation(30 Gyin10fractions).
Table 1 Clinical details of reported cases with the SMART syndrome
Age
(years)
Tumour CSF studies MRI radiation
Toxicity
Interval
(years)
Symptoms Original
tumour site
Radiation type and dose
Patient 1
male, 36
Pinealoma Protein 0.33
leukocytes 1
None 4 Headache
neurologic deﬁcit
seizures
Pineal region Craniospinal axis 36 Gy (20 9 1.8)
tumour booster 18 Gy (10 9 1.8)
Patient 2
male, 60
Brain metastases from
small-cell lung cancer
Protein 0.81
leukocytes 1
Diffuse white
matter
changes
10 Headache
neurologic deﬁcit
seizures
Both
hemispheres
WBRT 30 Gy (10 9 3)
Patient 3
male, 42
Oligodendroglioma Protein 0.43
leukocytes 1
Deep white
matter disease
2 and
5
Headache
neurologic deﬁcit
seizures
Left parietal
lobe
Focal 60 Gy (30 9 2)
Patient 4
male, 39
Astrocytoma Protein 0.71
leukocytes 2
None 5 and
10
Neurologic deﬁcit
seizures
Right
temporal
lobe
Focal 50 Gy (20 9 2.5)
Protein level in g/l
Interval, years between irradiation and the ﬁrst symptoms; Gy, radiation dose in Grays; X, number of radiation fractions; WBRT, whole-brain radiation therapy;
Focal, focal radiation on the original tumour site
Fig. 1 36-year-old man who was treated 4 years previously for
pineal tumor with radiation therapy, now presenting with headache
and left hemianopia. a T2 weighted, ﬂuid attenuated inversion
recovery (FLAIR) MR image showing diffuse gyral swelling and
signal increase in the right occipital lobe. b T1 weighted MR image
after gadolinium administration showing diffuse gyral and leptome-
ningeal enhancement. MR images obtained 9 month later showing
non residual signal abnormalities on FLAIR (c) and no abnormal
enhancement (d)
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123Ten years later he developed slowly progressive headache,
and a few weeks later he woke up with an expressive dys-
phasia. During hospitalization he developed a right sided
hemiparesis with right hemianopia and he suffered from
frequent focal epileptic seizures of the right arm and leg, for
which he received valproate and levetiracetam. MRI showed
focal gyral thickening and enhancement of the left parieto-
occipital lobe where metastases had not been observed
previously (Fig. 2a–d). Apart from diffuse leukoencepha-
lopathy, presumably due to the earlier brain radiotherapy,
there were no signs of recurrent brain metastases. Repeated
CSF analysis showed a slightly elevated protein level, but no
leptomeningeal metastases (Table 1). There were no clues
for extracranial tumour recurrence. During the hospital stay
he had a gradual clinical improvement and was discharged
fully recovered. A follow-up MRI 3 months after discharge
also showed complete resolution of the abnormalities in the
left parieto-occipital cortex (Fig. 2e, f).
Patient 3
In 1997 at the age of 42 years, this man suffered from an
epileptic seizure caused by an anaplastic oligodendrogli-
oma in the left hemisphere. The tumour was resected and
he subsequently received focal brain radiation (60 Gy in 30
fractions). He was discharged from hospital on valproate.
Two years later he was admitted to the hospital twice
within a short time period with reversible neurological
deﬁcits: dysphasia, right hemianopia, headache and neglect
of his right arm. Imaging showed no signs of recurrent
tumour, but possibly a small infarction in the left occipital
region and some diffuse white matter disease, possibly due
to radiation. An EEG showed no epileptic activity. Diag-
nosis of reversible ischemic neurological deﬁcit was
hypothesized, possibly due to former radiotherapy.
Three years thereafter he was again taken into hospital
with focal epileptic seizures of the right side of his face. He
suffered from headache, progressive aphasia, right hemia-
nopia and mild paresis of his right arm and leg. An MRI
scan now showed diffuse cortical enhancement of the left
occipital and temporal cortex (Fig. 3a, b). This enhance-
ment disappeared on a subsequent MRI performed 8 days
later (Fig. 3c, d). An EEG showed no epileptic activity.
Clinically, he recovered substantially.
Three years later he was again admitted to hospital
because of a new episode of worsening aphasia and paresis
of his right arm and leg.
MR imaging, similar to 3 years earlier, demonstrated
diffuse cortical enhancement of the left occipital and
temporal cortex (Fig. 3e, f). Although CSF examination
showed some atypical cells, he again partially recovered
spontaneously and almost completely, making leptome-
ningeal seeding unlikely (Table 1). A follow-up MRI scan
performed 1 month later again showed complete disap-
pearance of the contrast enhancement (Fig. 3g, h), and he
recovered afterwards in a rehabilitation centre. On longer
follow-up, he was treated successfully with temozolomide
chemotherapy for local tumour recurrence.
Patient 4
In 1999 at the age of 34 years, this man suffered from an
epileptic seizure caused by a right temporal anaplastic
Fig. 2 60-year-old man who was treated 10 years previously for
brain metastases of bronchial carcinoma with chemo- and radiation
therapy, now presenting with gradually progressive headache and
acute dysphasis. a T2 weighted MR image showing diffuse gyral
swelling and signal increase in the left parietal lobe. b T1 weighted
MR image after gadolinium administration showing abnormal
regional leptomeningeal enhancement. c T2 weighted FLAIR MR
image showing diffuse gyral swelling and signal increase in the left
occipital lobe. d T1 weighted MR image after gadolinium adminis-
tration showing abnormal leptomeningeal enhancement. MR images
after 4 months. e T2 weighted MR image no residual signal
abnormalities. f T1 weighted MR image after gadolinium adminis-
tration showing no abnormal leptomeningeal enhancement
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had focal brain radiation (50 Gy in 20 fractions). In the
following 5 years he had infrequent focal seizures of the
left arm but no tumour recurrence was observed on repe-
ated MRI. Five years after initial treatment, however, he
developed a progressive clumsy left hand, left-sided facial
paresis and dysarthria in combination with an increase of
focal seizures. An EEG showed nearly continuous epileptic
discharges diffusely over the right hemisphere. He was
treated with intravenous clonazepam and valproate. The
MRI demonstrated no tumour recurrence but a gyriform
enhancement and swelling of the right parieto-temporal
cortex (Fig. 4a–f).
CSF examination was, besides a slightly elevated protein
level, completely normal (Table 1). Over the following
weeks the focal seizures disappeared and the left sided
weakness improved. The patient was discharged from hos-
pital on valproate and nearly complete resolution of the
clinical picture. The abnormalities on MRI did partially
resolve (Fig. 4g, h). Three months later, a new MRI was
suggestive for recurrent tumour in the right temporal lobe,
showing several nodularenhancements. Abiopsy conﬁrmed
recurrent high-grade glioma, for which he was treated with
temozolomide. Following chemotherapy treatment, the
abnormal gyral and leptomeningeal enhancement tempo-
rarily disappeared, but recurred for which PCV chemo-
therapywasstarted.Again,acompleteresponseensued.Ten
years after the initial diagnosis of anaplastic astrocytoma he
developed left hemianopia and a clumsy left hand, but had
no seizures. On MRI a right occipital contrast enhancing
tumour was found, suggestive for recurrent tumour. Resec-
tion was planned, but pre-operative imaging showed the
lesion to be smaller and an open biopsy did not conﬁrm
activetumourgrowth.Postoperativelyhesufferedfromvery
frequent focal seizures of the left side of his face and a
clumsy left hand, which did not subside until he was put into
a propofol induced coma. He completely recovered within
several weeks. Follow-up MRI demonstrated the occipital
contrast-enhancing to have disappeared completely
(Fig. 4i–l). The patient died a year later from tumour
recurrence, 11 years after the initial diagnosis.
Discussion
All four patients had (partly) reversible neurological
symptoms as well as reversible imaging ﬁndings several
years after radiation therapy for their brain tumours. The
Fig. 3 47-year-old man who was treated 5 years previously for a left
parietal oligodendrolioma with chemo- and radiation therapy, now
presenting with right hemianopia and mild paresis of his right arm and
leg. T2 weighted FLAIR MR images a showing gyral swelling and
signal increase in the temporal lobe. b After gadolinium administra-
tion, diffuse gyral enhancement is seen in the occipital, temporal and
insular lobe. Proton density (c) and T1 post gadolinium (d)M R
imaging 8 days later showing normalization of signal intensity in the
temporal lobe and marked reduction in abnormal gyral enhancement.
After 3 years, the patient presented again with right sided paresis. MR
imaging again shows signal increase in the temporal lobe on PD
weighted images (e) while on T1 post gadolinium imaging (f) abnor-
mal gyral enhancement is again visible. Like after the previous
episode, the MR abnormalities disappeared (g, h)
c
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123combination of headaches in three of the four patients, as
well as development of new neurological deﬁcit and sei-
zures in all four patients was clinically suggestive for
tumour recurrence. However, neither local tumour recur-
rence, nor leptomeningeal disease were found to be the
cause of the clinical deterioration.
The radiological differential diagnosis of diffuse gyral
signal increase and leptomeningeal enhancement as
observed in these cases also includes vascular disorders
such as ischemia, venous sinus thrombosis and dural arte-
riovenous ﬁstula, and infection [6, 7]. Using CSF exami-
nation and additional radiological techniques such as
diffusion and perfusion weighted MRI and digital sub-
traction angiography, these potentially treatable causes
Fig. 4 38-year-old man who was treated 5 years previously for a
right temporal anaplastic astrocytoma with chemo- and radiation
therapy, now presenting with increasing epileptic activity and
gradually progressive left sided hemiparesis and dysarthria. T2
weighted FLAIR MR images (a, b) showing gyral swelling and signal
increase in the temporal lobe. T2 weighted MR image (c, d) showing
gyral swelling and signal increase in the temporal lobe. A post-
operative parenchymal defect is seen in the area of the previously
treated astrocytoma. T1 weighted MR images after gadolinium
administration (e, f) abnormal gyral and leptomeningeal enhancement
in the temporal lobe and in the basal frontal areas. No focal
enhancement in post-operative parenchymal defect. MR images 3 -
months later. g, h T1 weighted MR image after gadolinium
administration showing persistent gyral abnormalities but disappear-
ance of abnormal enhancement. MR images 6 months after treatment
for recurrent anaplastic astrocytoma using chemotherapy. i T2
weighted FLAIR MR image and j T1 weighted MR image after
gadolinium administration showing persistent gyral abnormalities but
disappearance of abnormal enhancement. MR images 6 months after
treatment for recurrent anaplastic astrocytoma using chemotherapy.
k T2 weighted MR image and l T1 weighted MR image after
gadolinium administration resolution of T2 abnormalities and disap-
pearance of abnormal enhancement in the deep temporal area
Fig. 4 continued
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123could be ruled out. Also post-ictal imaging changes
(swelling and enhancement) and posterior reversible
encephalopathy syndrome (PRES) as observed in patients
with hypertensive encephalopathy or following the use of
immunosuppressive agents should be considered [8, 9].
The episodic nature of the deﬁcits with spontaneous
resolution over weeks in combination with unilateral
enhancement and thickening of the posterior cortex on
MRI might suggest focal epileptic activity with long-last-
ing post-ictal deﬁcit as the cause of the clinical symptoms.
Yaffe and Ferreiro described eight patients who had all
been treated with systemic chemotherapy with comparable
reversible MRI changes following seizures. The majority
of the lesions involved grey and white matter, predomi-
nantly in the posterior vascular boundary zones [10]. This
phenomena was attributed to damage to the blood–brain
barrier by systemic chemotherapy in combination with
seizures. In our patients, however, damage to the parieto-
occipital blood brain barrier was presumably due to radi-
ation therapy. Irradiation affects primarily the vasculature
or the trigeminovascular system and engender a reversible
disturbance of homeostasis. Most previously presented
cases [2–4] had been treated with posterior fossa irradia-
tion, and it is presumed that the posterior lobes are speciﬁc
vulnerable for radiation damage. Regarding epileptic sei-
zures as the underlying mechanism, in two of our patients
the seizures occurred either before the development of MRI
abnormalities or after the MRI abnormalities had subsided.
Also, repeated EEG in three of four patients did not show
epileptic activity during the symptoms. Additionally, post-
ictal MRI abnormalities in patients without previous radi-
ation therapy or chemotherapy are not conﬁned to the pa-
rieto-occipital region [8]. We therefore argue that the MRI
ﬁndings as observed in our patients cannot be explained by
post-ictal enhancement alone. Reversible white matter
enhancement, but not cortical enhancement has been
described in patients with migraine [11, 12]. The under-
lying mechanisms of these transient imaging abnormalities
in migraine include meningeal and parenchymal hyper-
perfusion, edema or inﬂammatory plasma protein extrav-
asation after disruption of the blood brain barrier. Besides,
the prolonged duration of the symptoms in our patients,
who had no history of migraine headaches, are unlikely due
to migraine.
Otherwise, the clinical and radiological picture of these
patients is compatible with the SMART syndrome. SMART
syndrome involves transient, reversible neurological dys-
function which may include migrainous headache, at times
preceded by aura, prolonged hemispheric neurological
impairment and sometimes seizure activity [2, 3]. Neuro-
imaging studies of patients with SMART syndrome typi-
cally show focal gyral thickening of the affected cortex and
gyriform contrast enhancement. Before SMART was
deﬁned as a distinct syndrome, similar patients with sort-
like reversible MRI changes and clinical symptoms after
radiation were reported [5, 13–15].
The pathophysiology of the SMART syndrome is poorly
understood. A speciﬁc vulnerability of the parieto-occipital
cortex for radiation or chemotherapy, similar to that
observed in PRES, may explain why the imaging ﬁndings
are preferentially observed in this region [1]. Patient 2 had
been treated with whole-brain radiation and developed
parieto-occipital abnormalities in the left hemisphere, not
related to the original site of the brain metastases, which
supports this concept. The clinical presentation of PRES
has similarities with SMART, including headaches, neu-
rological deﬁcits and, more frequently than in SMART,
seizures. The pathophysiology of PRES is combined
vasoconstriction and vasodilation and has the same patterns
as seen in vasculopathy [9]. This results in blood brain
barrier disruption leading to symmetric hemispheric edema
and contrast enhancement on MRI [9]. Since radiation may
preferentially damage endothelial cells, the SMART syn-
drome might be a reversible radiation vasculopathy com-
parable with PRES. An alternative hypothesis is that post-
radiation neuronal dysfunction is the underlying mecha-
nism, such as in migraine or epilepsy, with impairment of
the trigeminovascular system or a lowered threshold for
cortical spreading depression [21].The parieto-occipital
cortical damage might even be the cause of epileptic sei-
zures rather than being the result of seizures [13].
Development of the SMART syndrome has been related
to a radiation dose of at least 50 Gy, as described in most
of the previous cases [3–5]. In our cases, a dose exceeding
50 Gy had only be applied to patients 1 and 3. In the other
two patients, however, the daily fraction doses were rela-
tively high (3 Gy in patient 2 and 2.5 Gy in patient 4,
respectively), which may have attributed to the radiation
toxicity.
Late effects of radiotherapy have mainly been blamed
on vascular endothelial injury and demyelination, and
include diffuse white matter changes or focal necrosis
with mass effect [16–18]. In contrast with the SMART
syndrome these late effects of radiation therapy are
gradual in onset and may have a progressive nature
[19, 20].
If these reversible, stroke-like migraine attacks are
related to remote radiation therapy, this relationship may
be under recognized so far because many patients did not
live long enough to experience these late treatment effects.
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